China Customs Seizes Over 265K Oral Nicotine Pouches; ‘ZYN’ and Unbranded Products Flagged for IP Violations

Oct.10.2025
China Customs Seizes Over 265K Oral Nicotine Pouches; ‘ZYN’ and Unbranded Products Flagged for IP Violations
China Customs seized 265,140 oral nicotine pouches, including “ZYN”-branded and unbranded products, over suspected IP infringement and breaches of tobacco export rules.

Key Points

 

· Total seizures (two cases): 265,140 boxes of oral nicotine pouches. China Ningbo Customs seized 255,740 boxes (“ZYN”: 212,960; unbranded: 42,780); China Huangpu Customs seized 9,400 boxes (all “ZYN”).

 

· Infringement & non-declaration: The China Ningbo Customs case involved undeclared, concealed goods; both cases involve suspected infringement of the “ZYN” trademark. In Ningbo, suspicion was identified after contacting the rightsholder; in Huangpu, the rightsholder confirmed the claim and requested Customs IP protection measures.

 

· Legal basis: Under Articles 44 and 91 of the Customs Law of the People’s Republic of China and the Regulations on Customs Protection of Intellectual Property Rights, infringing goods may be confiscated and fined; suspected crimes are subject to criminal liability.

 

· Regulatory classification: The tobacco authority has determined oral nicotine pouches are tobacco products. Exports require a Tobacco Monopoly transport permit and an export licence; concealment or evasion in export is illegal.

 


2Firsts, October 10, 2025 — According to China Customs on 3 October, China Ningbo Customs (Beilun) and China Huangpu Customs seized oral nicotine pouches during export inspections over suspected trademark infringement and non-declaration, totalling 265,140 boxes (222,360 “ZYN”-marked; 42,780 unbranded).

 

Case 1: China Ningbo Customs (Beilun) seizes 255,740 boxes

 

During inspection of a shipment declared as “party supplies,” officers found concealed, undeclared oral nicotine pouches—some bearing the “ZYN” mark, others unbranded.

 

After contacting the rightsholder, the “ZYN” pouches were deemed suspected of trademark infringement.

 

Count: 212,960 boxes of allegedly infringing “ZYN” pouches and 42,780 unbranded pouches, totaling 255,740 boxes.

 

Legal basis: Pursuant to Articles 44 and 91 of the Customs Law of the People’s Republic of China, customs protects IP related to import and export goods; goods that illegally infringe IP are subject to confiscation and fines; where a crime is constituted, criminal liability is pursued.

 

Sector oversight: As identified by the tobacco authority, oral nicotine pouches are tobacco products regulated by the Tobacco Monopoly Law of the People’s Republic of China and its implementing regulations. Concealing tobacco products for export is illegal; exporting tobacco products (including oral pouches) requires a Tobacco Monopoly transport permit from the State Tobacco Monopoly Administration and an export license.

 

Follow-up: The batch has been transferred for subsequent disposition.

 

China Customs Seizes Over 265K Oral Nicotine Pouches; ‘ZYN’ and Unbranded Products Flagged for IP Violations
Ningbo Customs (Beilun) seizes 255,740 boxes | Source: “Customs Release” video screenshot.

 

Case 2: China Huangpu Customs seizes 9,400 boxes of infringing “ZYN” pouches

 

During X-ray inspection of a shipment declared as “wristbands,” officers noted anomalies and opened the boxes, finding 9,400 boxes of oral nicotine pouches bearing the “ZYN” trademark.

 

After the rightsholder confirmed infringement of a trademark recorded with the GACC, they applied for customs IP protection measures.

 

Legal basis: Under the Regulations on Customs Protection of Intellectual Property Rights, customs shall confiscate and fine goods that illegally infringe IP; where a crime is constituted, criminal liability is pursued.

 

Follow-up: The batch has been transferred for subsequent disposition.

 

China Customs Seizes Over 265K Oral Nicotine Pouches; ‘ZYN’ and Unbranded Products Flagged for IP Violations
Huangpu Customs seizes 9,400 boxes of infringing “ZYN” pouches | Source: “Customs Release” video screenshot.

 

Legal & Regulatory Notes (per customs and tobacco authorities)

 

IP protection: Customs enforces protection of trademarks and other rights at the border under the Customs Law and the Regulations on Customs Protection of Intellectual Property Rights; infringing goods are subject to confiscation and fines, and suspected crimes are handled according to law.

 

Tobacco monopoly oversight: Oral nicotine pouches are tobacco products; export requires a Tobacco Monopoly transport permit and an export license; concealment or other illicit export methods are punishable.

 

Cover image source: “Customs Release.”

 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
According to Free Malaysia Today on August 26, 2026, Malaysia’s Health Minister Dzulkefly Ahmad said the Health Ministry would explain the government’s decision to withdraw its appeal against a High Court ruling involving the exemption of liquid nicotine used in vape products from the Poisons List. The High Court previously ruled that the exemption decision was irrational. Dzulkefly said withdrawing the appeal did not mean the government would stop regulating vaping, and that future regulatory approaches would continue under existing legal frameworks.
Aug.28